PHILADELPHIA--(BUSINESS WIRE)--Lannett Company, Inc. (AMEX:LCI), a manufacturer of generic pharmaceuticals, today announced it has acquired a privately-owned manufacturer/supplier of bulk active pharmaceutical ingredients (API). Financial terms of the agreement were not disclosed.
